A meeting held by Windsor's Diluted Chemotherapy Group Sunday afternoon triggered mixed reactions from those who attended.
On November 7, a proposed $2.375-million settlement was reached in a class action lawsuit stemming from watered-down chemotherapy drugs given to cancer patients.
Of the 1,200 patients affected by the drugs, 291 are from Windsor-Essex.
Many patients are not happy about receiving $1,500 cheques as a result of the lawsuit. Several recipients say they plan to file a motion of objection in court.
An advocate for the Diluted Chemotherapy Group, Colleen Marentette, says she is encouraging patients and their families to attend the court date of January 7, when a decision will be made about the fate of the settlement by a judge.
Marentette says she believes human life is worth more then $1,500.
"I cried," she said. "I said to my husband, 'Is this what they value of us?' It's not that we are looking for a value. You can not put a value on individual life."
Marentette says she believes she suffered more as a result of the diluted medicine.
"Because of [diluted] medication that I received, I ended up having my ovaries removed, I ended up having my lymph nodes removed afterwards," says Marentette. "I am over the top of the hill and now I am rolling down the mountain."
Those involved in the suit have until December 7 to accept or reject the settlement.
For more information on the Diluted Chemotherapy Group, email martens.louise@gmail.com